Renaissance Technologies’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Renaissance Technologies’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,800	Closed	-$283K	–	4291
2023 Q3	$283K	Buy	27,800 +13,600	+96%	+$104K	﹤0.01%	2953
2023 Q2	$67K	Buy	14,200 +1,100	+8%	+$5.06K	﹤0.01%	3559
2023 Q1	$61K	Buy	13,100 +300	+2%	+$1.32K	﹤0.01%	3615
2022 Q4	$46K	Buy	12,800 +500	+4%	+$2.22K	﹤0.01%	3813
2022 Q3	$58K	Sell	12,300 -34,500	-74%	-$173K	﹤0.01%	3719
2022 Q2	$227K	Sell	46,800 -84,300	-64%	-$513K	﹤0.01%	3596
2022 Q1	$834K	Sell	131,100 -125,900	-49%	-$678K	﹤0.01%	2850
2021 Q4	$1.6M	Buy	+257,000	New	+$2.01M	﹤0.01%	2324

Renaissance Technologies's THRN Position: Q4 2023 in Review

Renaissance Technologies sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 27,800 shares — an estimated $283K sold.

Renaissance Technologies first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $1.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Renaissance Technologies reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Renaissance Technologies sold 27,800 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $283K.
Renaissance Technologies first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Renaissance Technologies's Thorne Healthtech, Inc. Common Stock position peaked at $1.6M in Q4 2021.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.